35 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of KDM5A inhibitors: Homology modeling, virtual screening and structure-activity relationship analysis.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Sichuan University
Inhibition of Histone Demethylases Offers a Novel and Promising Approach for the Treatment of Cancer and Other Diseases.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Therachem Research Medilab (India)
Docking and Linking of Fragments To Discover Jumonji Histone Demethylase Inhibitors.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
University of Oxford
8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
The Institute of Cancer Research
Structure-Based Design of Selective Fat Mass and Obesity Associated Protein (FTO) Inhibitors.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
University of Oxford
Recent Advances with KDM4 Inhibitors and Potential Applications.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
St. Jude Children'S Research Hospital
Discovery of pyrazole derivatives as cellular active inhibitors of histone lysine specific demethylase 5B (KDM5B/JARID1B).![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Zhengzhou University
Lysine demethylase 5B (KDM5B): A potential anti-cancer drug target.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Zhengzhou University
Lead optimization of a pyrazolo[1,5-a]pyrimidin-7(4H)-one scaffold to identify potent, selective and orally bioavailable KDM5 inhibitors suitable for in vivo biological studies.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Genentech
Identification of novel lysine demethylase 5-selective inhibitors by inhibitor-based fragment merging strategy.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Kyoto Prefectural University of Medicine
C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-ones: Studies towards the identification of potent, cell penetrant Jumonji C domain containing histone lysine demethylase 4 subfamily (KDM4) inhibitors, compound profiling in cell-based target engagement assays.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Institute of Cancer Research
Design of KDM4 Inhibitors with Antiproliferative Effects in Cancer Models.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Celgene Quanticel Research
From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Genentech
The mouse 5HT5 receptor reveals a remarkable heterogeneity within the 5HT1D receptor family.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
Cnrs
Calorimetric Studies on the Complexation of Several Ferrocene Derivatives by .alpha.- and .beta.-Cyclodextrin. Effects of Urea on the Thermodynamic Parameters![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
University of Miami
Discovery and SAR of para-alkylthiophenoxyacetic acids as potent and selective PPARdelta agonists.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
Johnson & Johnson Pharmaceutical
Carbonic anhydrase inhibitors. Interaction of the antitumor sulfamate EMD 486019 with twelve mammalian carbonic anhydrase isoforms: Kinetic and X-ray crystallographic studies.![BDB](/images/logo_bindingdb.png)
![BDB](/images/logo_bindingdb.png)
Universita Degli Studi Di Firenze